xilis logo
GCB News

Shen and Hsu's startup Xilis present MicroOrganoSphere technology for cancer drug screening

Xilis, Inc., a pioneering company developing its MicroOrganoSphereTM (MOS) technology to guide precision therapy for cancer patients and accelerate drug discovery and development, announced today the presentation of data on the company’s proprietary MOS technology.

Center News

November 16, 2015

Statistical Genetics/Genomics Faculty Position

GCB, in conjunction with the Department of Biostatistics & Bioinformatics and the Center of Statistical Genetics and Genomics, invites applications for faculty positions at the Assistant Profes